NO | منتجات | كاس لا | مؤشر الجودة الرئيسي | |||
نقاء | الأعلى. شوائب | مجموع بقايا المذيبات | رُطُوبَة | |||
1 | fmoc-β-ala-ala-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
2 | fmoc-d-ala-d-ala-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
3 | fmoc-β-ala-d-ala-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
4 | FMOC-ARG (PBF) -ARG (PBF) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
5 | FMOC-β-ALA-ARG (PBF) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
6 | FMOC-D-ARG (PBF) -D-ARG (PBF) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
7 | FMOC-β-ALA-D-ARG (PBF) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
8 | FMOC-Homoarg (PBF) -HOMOARG (PBF) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
9 | FMOC-β-ALA-HOMOARG (PBF) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
10 | FMOC-ASN (TRT) -ASN (TRT) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
11 | FMOC-β-ALA-ASN (TRT) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
12 | fmoc-asp (otbu) -asp (otbu) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
13 | fmoc-β-ala-asp (otbu) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
14 | FMOC-CYS (TRT) -CYS (TRT) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
15 | FMOC-β-ALA-CYS (TRT) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
16 | FMOC-CYS (ACM) -CYS (ACM) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
17 | FMOC-β-ALA-CYS (ACM) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
18 | fmoc-gln (trt) -gln (trt) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
19 | fmoc-β-ala-gln (trt) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
20 | FMOC-GLU (OTBU) -GLU (OTBU) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
21 | fmoc-β-ala-glu (otbu) -oh.h2o | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
22 | fmoc-β-ala-gly-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
23 | fmoc-his (trt) -his (trt) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
24 | fmoc-β-ala-his (trt) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
25 | FMOC-ILE-ILE-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
26 | fmoc-β-ala-ile-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
27 | FMOC-LEU-LEU-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
28 | fmoc-β-ala-leu-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
29 | FMOC-D-LEU-D-LEU-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
30 | FMOC-β-Ala-D-Leu-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
31 | FMOC-LYS (BOC) -LYS (BOC) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
32 | FMOC-β-Ala-Lys (BOC) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
33 | FMOC-LYS (تخصيص) -lys (تخصيص) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
34 | fmoc-β-ala-lys (تخصيص) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
35 | fmoc-met-met-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
36 | fmoc-β-ala-met-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
37 | FMOC-ORN (BOC) -orn (BOC) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
38 | fmoc-β-ala-orn (boc) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
39 | fmoc-phe-phe-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
40 | fmoc-β-ala-phe-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
41 | FMOC-D-PHE-D-PHE-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
42 | fmoc-β-ala-d-phe-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
43 | fmoc-pro-pro-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
44 | fmoc-β-ala-pro-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
45 | FMOC-SER (TBU) -SER (TBU) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
46 | FMOC-β-ALA-SER (TBU) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
47 | FMOC-SER (TRT) -SER (TRT) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
48 | FMOC-β-ALA-SER (TRT) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
49 | FMOC-THER (TBU)-THR (TBU) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
50 | FMOC-β-ALA-THR (TBU) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
51 | FMOC-TRP (BOC) -TRP (BOC) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
52 | FMOC-β-ALA-TRP (BOC) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
53 | FMOC-D-TRP (BOC) -D-TRP (BOC) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
54 | FMOC-β-ALA-D-TRP (BOC) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
55 | FMOC-TYR (TBU) -TYR (TBU) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
56 | FMOC-β-ALA-TYR (TBU) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
57 | FMOC-D-TYR (ET) -D-TYR (ET) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
58 | fmoc-β-ala-d-tyr (et) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
59 | FMOC-TYR (ME) -TYR (ME) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
60 | fmoc-β-ala-tyr (me) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
61 | fmoc-val-val-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
62 | fmoc-β-ala-val-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
63 | FMOC-D-CIT-CIT-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
64 | fmoc-β-ala-d-cit-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
65 | fmoc-β-ala-dab-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
66 | FMOC- (3- (2-naphthyl) -d-ala) 2-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
67 | fmoc-β-ala-3- (2-naphthyl) -d-ala-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
68 | fmoc- (3- (3-pyridinyl) -d-ala) 2-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
69 | fmoc-β-ala-3- (3-pyridinyl) -d-ala-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
70 | FMOC- (4-Chloro-D-PHE) 2-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
71 | FMOC-β-ALA-4-Chloro-D-PHE-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
72 | FMOC- (D-4APH (TBUCBM)) 2-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
73 | FMOC-β-ALA-D-4APH (TBUCBM) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
74 | fmoc-aph (l-hor) -aph (l-hor) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
75 | fmoc-β-ala-aph (l-hor) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
76 | FMOC-LYS (IPR ، BOC) -LYS (IPR ، BOC) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
77 | FMOC-β-Ala-Lys (IPR ، BOC) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
78 | fmoc-β-ala-aeea-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
79 | FMOC-AIB-AIB-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
80 | fmoc-β-ala-aib-oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
81 | FMOC-ARG-OH | 91000-69-0 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
82 | H-ARG (PBF) -OH | 200115-86-2 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
83 | FMOC-D-ARG-OH | 130752-32-8 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
84 | HD-ARG (PBF) -oh | 200116-81-0 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
85 | fmoc-homoarg-oh.hcl | 208174-14-5 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
86 | H-Homoarg (PBF) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
87 | FMOC-D-HOMOARG-OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
88 | HD-Homoarg (PBF) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
89 | fmoc-asn-oh | 71989-16-7 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
90 | H-Asn (TRT) -oh | 132388-58-0 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
91 | FMOC-ASP-OH | 119062-05-4 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
92 | H-ASP (OTBU) -oh | 3057-74-7 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
93 | fmoc-cys-oh | 135248-89-4 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
94 | H-Cys (TRT) -oh | 2799/7/7 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
95 | H-Cys (ACM) -oh.hcl | 28798-28-9 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
96 | fmoc-gln-oh | 71989-20-3 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
97 | H-GLN (TRT) -OH | 102747-84-2 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
98 | fmoc-glu-oh | 121343-82-6 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
99 | H-Glu (Otbu) -oh.h2o | 2419-56-9 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
100 | fmoc-his-oh | 116611-64-4 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
101 | H-His (TRT) -oh | 35146-32-8 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
102 | boc-his-oh | 17791-52-5 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
103 | FMOC-LYS-OH | 105047-45-8 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
104 | H-Lys (BOC) -oh | 2418-95-3 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
105 | H-Lys (تخصيص) -oh | 6298/3/9 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
106 | FMOC-ORN-OH.HCL | 201046-57-3 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
107 | H-ORN (BOC) -OH | 13650-49-2 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
108 | FMOC-SER-OH | 73724-45-5 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
109 | H-ser (TBU) -oh | 18822-58-7 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
110 | H-ser (TRT) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
111 | FMOC-THR-OH.H2O | 73731-37-0 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
112 | H-THER (TBU) -oh | 4378-13-6 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
113 | FMOC-TRP-OH | 35737-15-6 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
114 | H-TRP (BOC) -OH | 146645-63-8 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
115 | FMOC-D-TRP-OH | 86123-11-7 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
116 | HD-TRP (BOC) -OH | 201290-11-1 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
117 | FMOC-TYR-OH | 92954-90-0 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
118 | H-Tyr (TBU) -oh | 18822-59-8 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
119 | FMOC-D-TYR-OH | 112883-29-1 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
120 | HD-TYR (ET) -OH | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
121 | H-Tyr (ME) -oh.hcl | 67423-44-3 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
122 | FMOC-D-4APH (CBM) -OH | 324017-22-3 | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
123 | HD-4APH (tbucbm) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
124 | fmoc-les (IPR) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
125 | H-Lys (IPR ، BOC) -oh | NA | 98.0 ٪ | ≤1.0 ٪ | ≤8.0 ٪ | ≤2.0 ٪ |
تعويض
توفر Gentolex منتجات ذات جودة عالية ، إذا تم رفع أي جودة من المنتج من قبل العميل ضمن الإطار الزمني المطلوب مع أدلة كافية ، فسنقدم التحليل والتقييم اللازمين لإثارة إجراءات التعويضات.
إنتاج
وصلت قدرات المنتجات الصيدلانية إلى درجة الأطنان ، وتصل قدرات المنتجات الكيميائية إلى 100 تونز+ درجة ، والقدرات مجهزة تجهيزًا جيدًا لخدمة العملاء في جميع أنحاء العالم.
البحث والتطوير
كل عام ، هناك خطة أنشأها فريق البحث والتطوير لتطوير منتجات جديدة مختلفة ، عندما يتم تحديد الأهداف ، سيتعين على كل عضو في الفريق الاستمرار في مسؤولية مؤشرات الأداء الرئيسية وسياسة الحوافز.